Compare
Integer Holdings Corp vs LivaNova PLC vs Axogen, Inc. vs Outset Medical, Inc.
| Latest fiscal year | Integer Holdings Corp ITGR | LivaNova PLC LIVN | Axogen, Inc. AXGN | Outset Medical, Inc. OM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.85B | $1.39B | $225.21M | $119.48M |
| Revenue growth (YoY) | +8.0% | +10.7% | +20.2% | +5.1% |
| Gross margin | 27.0% | 67.7% (computed) | 74.3% | 39.1% |
| Operating margin | 11.9% | 14.4% | -3.5% | -55.8% |
| Net margin | 5.5% | -17.5% | -7.0% | -68.3% |
| Net income | $102.81M | -$242.47M | -$15.70M | -$81.65M |
| EPS (Diluted) | $2.89 | -$4.45 | -$0.34 | -$5.37 |
| Operating cash flow | $196.15M | $254.34M | $812.0K | -$46.33M |
| Free cash flow | $105.12M | $173.29M | -$2.93M | -$47.12M |
| Cash & equivalents | $17.16M | $635.55M | $35.55M | $35.01M |
| Total assets | $3.41B | $2.61B | $221.69M | $264.50M |
| Total liabilities | $1.66B | $1.41B | $92.84M | $137.54M |
| Shareholders' equity | $1.75B | $1.20B | $128.85M | $126.95M |
| Return on year-end equity | 5.9% | -20.2% | -12.2% | -64.3% |
| Shares outstanding | 34.35M | 54.65M | 47.20M | 18.17M |
Revenue, most recent five fiscal years
| Fiscal year | Integer Holdings Corp | LivaNova PLC | Axogen, Inc. | Outset Medical, Inc. |
|---|---|---|---|---|
| Latest | $1.85B Ended 2025-12-31 | $1.39B Ended 2025-12-31 | $225.21M Ended 2025-12-31 | $119.48M Ended 2025-12-31 |
| 1 year earlier | $1.72B Ended 2024-12-31 | $1.25B Ended 2024-12-31 | $187.34M Ended 2024-12-31 | $113.69M Ended 2024-12-31 |
| 2 years earlier | $1.56B Ended 2023-12-31 | $1.15B Ended 2023-12-31 | $159.01M Ended 2023-12-31 | $130.38M Ended 2023-12-31 |
| 3 years earlier | $1.33B Ended 2022-12-31 | $1.02B Ended 2022-12-31 | $138.58M Ended 2022-12-31 | $115.38M Ended 2022-12-31 |
| 4 years earlier | $1.22B Ended 2021-12-31 | $1.04B Ended 2021-12-31 | $127.36M Ended 2021-12-31 | $102.60M Ended 2021-12-31 |